Medication use in infants with severe bronchopulmonary dysplasia admitted to United States children’s hospitals

• Published in: Journal of perinatology Vol. 39; no. 9; pp. 1291 - 1299
• Main Authors: Bamat, Nicolas A., Kirpalani, Haresh, Feudtner, Chris, Jensen, Erik A., Laughon, Matthew M., Zhang, Huayan, Monk, Heather M., Passarella, Molly, Lorch, Scott A.
• Format: Journal Article
• Language: English
• Published: New York Nature Publishing Group US 01.09.2019; Nature Publishing Group
• Subjects: 692/308/174; 692/699/1785; 692/700/1720; Babies; Birth weight; Bronchopulmonary dysplasia; Bronchopulmonary Dysplasia - drug therapy; Children; Diuretics; Drug therapy; Drug Utilization - statistics & numerical data; Drugs; Dysplasia; Exposure; Female; Furosemide; Gestational Age; Hospitalization; Hospitals; Hospitals, Pediatric; Humans; Infant, Newborn; Infant, Premature; Infants; Intensive Care Units, Neonatal; Lung diseases; Male; Medicine; Medicine & Public Health; Ostomy; Pediatric Surgery; Pediatrics; Premature birth; Retrospective Studies; United States; Ventilators; United States; United States > US

Objective To identify the number of cumulative medication exposures and most frequently used medications in infants with severe BPD. Study design We performed a retrospective cohort study in infants with severe BPD admitted to United States children’s hospitals. We measured cumulative medication exp...